IPOPLUS

17,016

+294 +1.76%

17 Jun 2026

NSE Listed · Pharmaceuticals

Neuland Lab Ltd. (NEULANDLAB)

Volume: 1,218Avg Vol 1W: 1,251Avg Vol 1M: 4,23052W Range:11,50019,747
₹17,016 1.76%
Market Cap₹22,039 Cr
Current Price₹17,016
Previous Close₹16,722
High / Low (52w)₹19,747 / ₹11,500
Volume1,218
Avg Vol (1W)1,251
Avg Vol (1M)4,230
Stock P/E59.9
Book Value₹1,453.08
Dividend Yield0.2%
ROE19.42%
ROA12.42%
Revenue (TTM)
Revenue Growth-5.24%
Profit Margin17.99%
Total Debt₹91 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹165.76
P/B12.08
Debt / Equity0.16
50 DMA₹16,323.73
200 DMA₹14,191.82
Day change+1.76%
Price Chart
17,016 10.86% · 1Y
18109115404.4L
2025-10-01
2026-06-16

20-day avg volume: 4K shares

Pros
  • Healthy return on equity of 19.4%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 60.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹776 Cr₹440 Cr₹514 Cr₹293 Cr₹328 Cr₹398 Cr₹311 Cr₹440 Cr₹385 Cr₹393 Cr₹418 Cr₹363 Cr₹407 Cr₹269 Cr₹294 Cr₹221 Cr₹256 Cr₹236 Cr₹258 Cr₹201 Cr₹245 Cr₹245 Cr₹241 Cr₹205 Cr₹192 Cr
EBITDA₹295 Cr₹61 Cr₹135 Cr₹22 Cr₹42 Cr₹74 Cr₹50 Cr₹112 Cr₹96 Cr₹108 Cr₹126 Cr₹85 Cr₹114 Cr₹42 Cr₹56 Cr₹16 Cr₹27 Cr₹22 Cr₹31 Cr₹16 Cr₹29 Cr₹36 Cr₹32 Cr₹26 Cr₹24 Cr
Net Profit₹213 Cr₹41 Cr₹97 Cr₹14 Cr₹28 Cr₹102 Cr₹33 Cr₹98 Cr₹68 Cr₹81 Cr₹89 Cr₹62 Cr₹85 Cr₹31 Cr₹38 Cr₹10 Cr₹22 Cr₹13 Cr₹20 Cr₹9 Cr₹17 Cr₹27 Cr₹21 Cr₹15 Cr₹-9 Cr
EPS165.7631.6275.4910.8321.6779.1825.676.2852.6663.4469.5648.2365.923.8129.977.7716.9710.0815.886.8113.4820.8416.7111.82-7.25
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹1,497 Cr₹1,571 Cr₹1,201 Cr₹953 Cr₹953 Cr₹767 Cr
EBITDA₹278 Cr₹415 Cr₹229 Cr₹96 Cr₹123 Cr₹74 Cr
Net Profit₹260 Cr₹300 Cr₹164 Cr₹64 Cr₹81 Cr₹16 Cr
EPS202.74233.89127.4549.7462.8512.63
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹2,180 Cr₹1,833 Cr₹1,580 Cr₹1,383 Cr₹1,325 Cr₹1,231 Cr
Total Liabilities₹655 Cr₹550 Cr₹586 Cr₹543 Cr₹538 Cr₹521 Cr
Equity₹1,525 Cr₹1,283 Cr₹994 Cr₹841 Cr₹786 Cr₹710 Cr
Total Debt₹91 Cr₹45 Cr₹74 Cr₹104 Cr₹88 Cr₹77 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹392 Cr₹373 Cr₹281 Cr₹81 Cr₹195 Cr₹62 Cr
Investing₹-298 Cr₹-150 Cr₹-61 Cr₹-96 Cr₹-84 Cr₹-49 Cr
Financing₹25 Cr₹-69 Cr₹-136 Cr₹38 Cr₹-114 Cr₹-5 Cr
Free Cash Flow₹392 Cr₹373 Cr₹281 Cr₹81 Cr₹195 Cr₹62 Cr
Shareholding
Promoter 32.63% Institutions 36.3% Public 31.07%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search